MEDICAL RESEARCH FOUNDATION
SANKARA NETHRALAYA
41/18 COLLEGE ROAD,
NUNGAMBAKKAM
Chennai, 600006
Advertisement for Project Associate position in research project funded by DST-SERB
Applications are invited for one position of Project Associate in a research project funded
by DST-SERB, Govt of India, at the Microbiology department, Medical Research Foundation,
Chennai. The proposed project will present the candidate with a unique opportunity to explore
ocular microbiome in various healthy and diseased populations.
Title of the project: “Metagenomic analysis of ocular surface microbiome in health and
disease”
Principal Investigator: Dr. A.R. Anand , Senior Associate Professor, Microbiology
Department, Medical Research Foundation, Chennai.
Duration of the project: Three years
Qualifications:
a) Essential : M.Sc/M.Tech Life Sciences.
b) Desirable: Candidates should have qualified NET (CSIR-UGC) or GATE or any other
national eligibility examination.
Previous research experience in molecular biology and
microbiology will be an added advantage. Candidates should possess good
communication and writing skills.
Age Limit: Not more than 35 years as on 10.12.2023. Age relaxation as per DST-SERB
guidelines.
Fellowship: Rs. 31000/- + 24% HRA per month (Consolidated) for the candidate who possesses
valid CSIR / UGC-JRF / NET / GATE / Qualified National Level Test conducted by Central
Govt. Depts and their agencies along with minimum qualification
Rs. 25,000/- + 24% HRA per month (Consolidated) for the candidate who possesses only
minimum qualification
Terms and conditions: As per DST-SERB guidelines and MRF norms.
The position is
temporary and co-terminus with the project
Application: Interested candidates can send their applications with their detailed CV on or
before 10.12.2023 by email to dranand@snmail.org and hr@snmail.org. Shortlisted candidates will
be intimated by e-mail informing date and time of interview.
www.sankaranethralaya.org/pdf/announcement/project-associate-in-a-research-project-funded-by-dst-serb-02122023.pdfSubscribe our Twitter Channel to get Latest and more updates: Join Now!
0 Comments